DRUG PROGRAM WILL ASSIST NEW PART D PATIENTS
Community Care Rx (CCRx) recently launched its Welcome toCCRx Medication Review Program, a program created to helpnew members and improve their transition into CCRx'sMedicare Part D plan. The outcome elevates the quality of careto beneficiaries through face-to-face meetings with their communitypharmacists for a timely review of their drug regimensas they enroll in the prescription drug benefit. The MedicationReview Program will be a reimbursable service for pharmacists.
CCRx officials are aware that one-on-one encounters withthe patient's pharmacists can be more effective to guaranteeclinically appropriate and timely medication transitions. Duringa Medication Review, community pharmacists will work withCCRx beneficiaries to evaluate their current medication use andmake suggestions related to the following:
- Clinical concerns, including potentially harmful druginteractions
- Transition planning for drugs that are not part of theCCRx formulary
- Ways to reduce beneficiaries'costs by switching toless expensive or preferred brand drugs
"We believe that CCRx is taking a gigantic step in theright direction by engaging the services of the communitypharmacist to better care for Medicare beneficiaries," saidBruce Roberts, RPh, executive vice president and chiefexecutive officer for the National Community PharmacistsAssociation. "Community pharmacists are medicationexperts, and their patients have a high comfort level andtrust in them."
Articles in this issue
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
Advise Patients About Self-Care Measures to Treat Mild to Moderate GI IssuesSeptember 18th 2025
Evaluation of Pharmacist-Driven Penicillin Allergy ReconciliationSeptember 17th 2025
Pharmacists Can Apply Their Expertise to the Medical Psilocybin ActSeptember 16th 2025
From Curiosity to Clinical Impact: Shremo Msdi’s Path in Pharmacy ResearchSeptember 15th 2025
